Pharmaceuticals & Biotechnology | Pharma & Biotech Resources

An urgent problem facing R&D is the ability to create innovative new products at a cost and speed to market that will accelerate corporate growth. Innovation complexity and the distances and communication barriers that come with globalisation make management of innovation projects

Dr. Di Wu is the Director of Laboratory for International Research and Relations at Clinical Pharmacology & Therapeutics (CPT) in Children’s Hospital of Philadelphia (CHOP) and a Guest Professor at Central South University & Third Xiangya Hospital. Dr. Wu currently serves

The lengthy clinical development process of drug development for life threatening diseases is not an optimal development strategy for oncology therapeutic area. Adaptive designs have become popular tools in oncology research, helping to achieve validity, efficiency and speed in clinical

Simon Mortimore, Head of Information Services, University College London Hospitals NHS Foundation Trust, joins Helen Winsor from Pharma IQ, to discuss developments and challenges in e-health and informatics. First, he explains exactly what management information strategy is and why

Kieran O’Doherty, PhD, Assistant Professor, University of Guelph, talks to Andrea Charles from Pharma IQ, about ethical, legal, and social issues surrounding biobanks, and how ethical principles prevent or promote the sharing of stored biological resources. O'

Marc Descamps, Professor in Solid State Physics at Université Lille and Lead of the European ID Network for Improved Drug Efficacy and Availability, joins Helen Winsor from Pharma IQ, to discuss the use of amorphous pharmaceutical materials to improve necessary drug properties. He

Soren Skovlund, Director of Patient Research, Advocacy and Support at NovoNordisk, joins Helen Winsor from Pharma IQ, to discuss best practice approaches to patient education and self management. Firstly, Skovlund talks about how NovoNordisk approaches the issue of patient education and

The role of CRO s in the drug discovery process is constantly evolving, and as data management and distribution efforts improve, there is increased opportunity for leveraging CROs within Drug Discovery research. In this podcast, Rose Gonzales, Director at Pfizer, talks about the ever

According to FDA guidelines for medical device manufacturers, decision making for reportability purposes to regulatory authorities is required within 30 days of a potential complaint reception. In this podcast, Sebastian Fishman, Project Coordinator at Allergan Medical, joins us to

Patricia DeCock, Medical Affairs Manager Diabetes at Sanofi Aventis, joins Pharma IQ to discuss the problems associated with patient adherence to treatment of Type 1 and 2 diabetes, in paediatrics, adolescents and adults. In this exclusive interview, DeCock outlines the origins and

Frank Binder, Director of International Logistics and Supply Chain at Celgene, joins Helen Winsor at Pharma IQ, to discuss how pharmaceutical distribution can add more value to business. Firstly, he discusses the importance of the ‘last mile’ to the overall supply

Nicolas Favre, International Brand Manager, Azilect at Lundbeck, joins Pharma IQ to discuss the commonly experienced patient adherence challenges for Parkinson’s Disease sufferers. He also outlines the best strategy for success in increasing adherence in patients with PD, and

Steve Jacobs, Chair of the Global Clinical Suppliers Group and President of Global BioPharm Solutions, joins Helen Winsor from Pharma IQ, to discuss how to go about creating the best sponsor/vendor partnership and how to balance cost versus service. He also discusses whether it is

In this Pharma IQ interview, Tina Spendler, Project Manager at Novozymes, talks to John Trigg , Director of phaseFour Informatics. Spendler explains the background to Novozymes' decision to use SharePoint as the platform for their ELN . She also talks about user reaction to the

Mark Gibson, Consumer Information Specialist at Gibson Research Consultancy, joins Helen Winsor form Pharma IQ, to discuss packaging and labelling in the healthcare industry. In this exclusive interview, Gibson outlines the main considerations in labelling translation, the key